Textiles digital sensors for detecting breathing frequency

Objectives: Diabetic patients can suffer from poor bone quality and impaired vascularity often leading to increased fracture risk, delayed healing and potential fracture nonunion. Therefore, this study assessed healthcare resource utilization by diabetic patients receiving electrical bone growth stimulation (EBGS) versus Low-intensity Pulsed Ultrasound Stimulation (LIPUS) or neither (No-stim) for the management of their fracture nonunions. Methods: Diabetic and non-diabetic patients newly diagnosed with a fracture nonunion were identified using medical and pharmacy claims and stratified by the first treatment received after nonunion diagnosis: EBGS, LIPUS, or No-stim. Patient demographics, comorbidities, fracture characteristics, and healthcare costs were analyzed before and after nonunion diagnosis. Multivariate regression analysis was used to compare healthcare costs incurred during nonunion fracture management for the different treatment cohorts. Results: After controlling for demographic and clinical characteristics in the diabetic group, EBGS was associated with significantly lower total healthcare costs when compared with the No-stim cohort (marginal difference: -$11,834, p<0.01) and significantly lower fracture-related costs when compared to both the LIPUS (marginal difference: -$3,016, p=0.02) and the No-stim (marginal difference: -$4,783, p<0.01) cohorts. LIPUS was associated with significantly lower total healthcare costs (marginal difference: -$8,743, p=0.01), but similar fracture-related costs (marginal difference: -$1,767, p=0.23) when compared to the No-stim cohort. In the non-diabetic group a similar trend was observed as EBGS was associated with significantly lower costs when compared to the other cohorts. Conclusions: Study results suggest that EBGS is associated with lower healthcare costs in the management of fracture nonunions in both diabetic and non-diabetic patients.

The association between outpatient continuation/maintenance electroconvulsive therapy, readmission risk and total direct cost in patients with depressive, bipolar and psychotic disorders: A naturalistic retrospective cohort study

Duloxetone treatment patterns and healthcare costs among fibromyalgia patients with medicare supplemental insurance

Objective:To examine the impact of medication choice between duloxetine or pregabalin on medication adherence and direct healthcare costs among patients with diabetic peripheral neuropathic pain (DPNP).Methods:A retrospective cohort study design was used with a large US national administrative claims database. Commercially-insured DPNP patients aged 18–64 years who initiated duloxetine or pregabalin in 2006 were selected, with the first initiation date as the index date. All selected patients had 12 months continuous enrollment in the pre- and post-index periods, and were grouped into the duloxetine or pregabalin cohort based on the index agent. The duloxetine and pregabalin cohorts were constructed via propensity score stratification with similar demographics, co-morbid medical conditions, pre-index healthcare utilization and costs, and prior treatment patterns. Medication possession ratio (MPR), proportion of patients with MPR ≥ 0.8 and healthcare costs over the 12-month post-index period were compared between cohorts.Results:Both the duloxetine (n = 794) and pregabalin (n = 1779) cohorts had a mean age of 56 years, and 58% of female. Common co-morbid conditions among duloxetine and pregabalin patients were cardiovascular disease (82.5 vs. 82.2%), neuropathic pain other than DPNP (71.1 vs. 72.7%), osteoarthritis (39.0 vs. 41.3%), and low back pain (29.4 vs. 30.5%). More than 73% of the patients had opioid use prior to the initiation of duloxetine or pregabalin. Among patients with similar demographic, clinical and economic characteristics, and prior treatment patterns, duloxetine-treated patients had significantly higher MPR (0.34 vs. 0.13), higher proportion of patients with MPR ≥ 0.8 (15.5 vs. 0.7%), and significantly lower total healthcare costs ($34 146 vs. 34 897) over the 12-month post-index period than pregabalin-treated patients (all p < 0.05).Conclusions:Commercially-insured DPNP patients initiating duloxetine had significantly higher medication adherence and lower healthcare costs than those initiating pregabalin.

Textile sensors have attempted to measure heart rate, respiratory rate, as well as moving performance. The characteristics of conductivity and elasticity of textile are used to measure angle and performance. In this chapter, the principles of motion analysis using conventional optical method, inertial sensors, and textile sensors are briefly presented. In particular, overview of textile sensors in terms of conductivity and elasticity is explained. Finally, the current topics of sensor application are introduced.

Shared savings contracts between physician networks/health maintenance organisations and insurances or sickness funds in Germany and Switzerland showed quite impressive results of between 5 and 15% savings, similar to those being demonstrated in the US during the 1990s in the beginning of managed care last century. While managed care in the US got into a lot of ethical questions the European examples are on the rise and a new international debate on integrated care is emerging.The ‘triple aim’ as Donald M. Berwick emphasized in his famous Health Affairs article in 2008 called for better health, improved care and lower health care costs and the Obama administration took this notion into its new accountable care organisation approach. The author suggests that it is time to develop comprehensive integration policies for whole regional populations. He can tear on at least five years of experiences in Germany (GesundesKinzigtal) as well as on several years of experiences of other networks in Switzerland and other parts of Germany.These experiences are indicating that effective trans-sector organisation of health care and increased investments in well-designed preventive programmes will lead to a reduction in morbidity, and in particular to a reduced incidence and prevalence of chronic diseases and offer substantial efficiency gains for sickness funds and health insurances.

Cyclic hardening behavior and deformation mechanisms of friction-stir-welded dissimilar AA5083-to-AA2024 joints with heterogeneous microstructures

This study aims to study the physiological response shown by broiler chickens to cage temperatures at different times. A completely randomised design was used in this research, with three treatments and five replications of each. The treatments were the average temperature of the cage in the afternoon (30.15oC) , afternoon (27.04oC), and morning (26.01 °C). Each treatment was repeated six times, and each replication consisted of 5 chickens. The variables measured in this study are respiratory rate, heart rate, and rectal temperature in broiler chickens. If the results of the analysis of variance show that there is a significant difference between treatments, it is continued with the Duncan Multiple Range test. The results showed that the temperature of the cage during the day significantly increased the frequency of breathing of broiler chickens (74.90 times/minute), heart rate (279.50 times/minute), and rectal temperature (41.53 oC) compared to the frequency of breathing (57 times). ,27 times/minute and 55.77 times/minute), heart rate (274.07 times/minute and 272.47 times/minute), and rectal temperature (40.74oC and 40.61oC) In the afternoon and the morning, it can be concluded that the temperature of the cage during the day resulted in the frequency of breathing, heart rate and rectal temperature in broilers which were significantly higher than the temperature of the cell in the afternoon and morning, while the temperature of the cell in In the afternoon, the respiratory frequency, heart rate, and rectal temperature were not significantly higher than the cage temperature in the morning.

Allergy immunotherapy: Reduced health care costs in adults and children with allergic rhinitis

Read the full review for this Faculty Opinions recommended article: Hepatitis C virus therapy is associated with lower health care costs not only in noncirrhotic patients but also in patients with end-stage liver disease.

A growing number of elderly people in Poland and Europe forces us to look for new solutions for the continuous monitoring of their health state. This approach allows an early action in case of dangerous situations for elderly persons' life (state before a heart attack or a stroke, etc.). The system for continuously monitoring the health state also allows a quick action of first contact doctors in the case of emergency situations. That described system also allows the remotely monitoring of elderly people in their homes by their relatives. The monitoring system is portable, comfortable to use and uses non-invasive measurement methods. That kind of clothing is a fully user-friendly product. The textronics system is a new product for monitoring selected human physiological parameters such as: pulse, frequency of breathing, underclothing temperature, positioning inside and outside the house. Textile sensory elements and signal lines are implemented in the structure of the clothing and that is a main innovation of that kind of systems. System of a textile sensor is part of a garment, the monitoring system is fully portable, easy for using, does not require specialized medical services. Furthermore, measurement of physiological parameters is non-invasive which means that does not interfere directly in the human body. The system is completely safe, because it is supplied by a miniature battery such as the ones that are used in mobile phones. The combination of textile clothing interface with specialized software for data acquisition and generation of alarm signals provides a continuous overview of the health status of the monitored person.

<b>Backgroung</b> In moderate to severe COPD patients, ventilation adaptation to metabolic demand during concentric exercise (CONC) is often limited by dynamic hyperinflation that impedes tidal volume (Vt) to increase. According to its low metabolic cost, eccentric exercise (ECC) could be an alternative to CONC with these patients. <b>Aims and objectives</b> To compare ventilatory adaptation during CONC and EXC cycling in moderate to severe COPD patients. <b>Methods</b> On 5 separate days, 13 patients (FEV1: 42±9% pred) performed a symptom-limited incremental CONC cycle exercise test followed by four 30-min sessions of constant-load ECC cycling. Load of ECC exercise was increased by 50% at each session. Vt, breath frequency (BF) and several physiologic parameters were compared at the maximal common minute ventilation (V9E) observed during CONC and ECC (iso-V9E). <b>Results</b> Iso-V9E was 24.9±7.9 L.min^-1 duringECC and 24.9±7.8 L.min^-1 during CONC (61±21% of maximal estimated ventilation). The power outputs at isoV9E were 37±16 W and 104±18 W for CONC and ECC, respectively. At iso-V9E, Vt was 22% lower in ECC than in CONC (890±220 <i>vs.</i> 1080±320 mL; <i>p</i>=0.005) and BF was 24% higher (28.3±5.6 vs. 22.8±3.1 min^-1; <i>p</i>&lt;0.001). However, heart rate (HR), oxygen consumption (V9O₂) and Borg dyspnoea score were similar in both conditions (HR: 95.4±13.1 <i>vs.</i> 95.4±12.5 min^-1; V9O₂: 0.74±0.23 <i>vs.</i> 0.77±0.26 L; Borg: 2.4±2.4 <i>vs.</i> 1.7±0.9 in ECC and CONC, respectively; p&gt;0.05). <b>Conclusion</b> At an identical V9E of about 60% of maximal estimated ventilation, patients with moderate to severe COPD have a 24% higher breathing frequency during ECC compared with CONC cycling. The mechanisms and consequences of this hyperpnoea deserve further studies.

Setting of noninvasive pressure support in young patients with cystic fibrosis.

Acute chest pain is one of the most common reasons for ED visits in the United States. Most patients are eventually admitted to the hospital to "rule out ACS" even when there are no significant EKG abnormalities or elevated cardiac enzymes. In addition to undergoing expensive tests while in the hospital, patients are also exposed to iatrogenic harm thereby worsening the overall healthcare costs. Meanwhile, the use of coronary computed tomography angiography (CTA) as a "gatekeeper" diagnostic test for patients with low to intermediate risk for coronary artery diseases (CADs) has significantly lowered hospital admissions and associated costs. However, coronary CTA may not be helpful for all classes of patients. Therefore,this study seeks to determine if the distribution ofpatients presenting to the ED withchest pain in an acute care facility will justify an investment in coronary CTA and contribute to lowering healthcare costs. Patients' data between July 2022 and June 2023 were considered in our analysis. Results revealed that a significant number of patients who presented to the ED for chest pain and were subsequently admitted to the hospital for further work-up would have benefited from coronary CTAscreening without any need for further inpatient work-up. Also, cost analysis showed that the use of coronary CTA would have helpedsignificantly lower healthcare costs in this facility.

The future of personalized medicine will be built on a foundation of knowing all disease-causing genes and variants, and the ability to diagnose disease with precision informed by this knowledge. This "solving of disease," in terms of gene discovery and resulting diagnostics, is made possible by advances in genome sequencing technology, and progress towards the "$1000 genome." Here, we give an overview of the status of this, and the major global projects that are deploying genome sequencing to solve and diagnose disease on the population-scale. We further outline the key design considerations and ideal architecture for such projects, as a model for countries to follow as they fully personalize medicine for their unique genetic backgrounds. A critical point is the need for global enterprise service providers that can provide end-to-end support for countries building out their capacity for genomic medicine. This is essential for delivering the benefits of genomic medicine – lower healthcare costs and improved patient care – globally, as quickly as possible, by removing the risks, gaps, and bottlenecks that will otherwise stall or derail such large, complex projects.